3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide
C21H17N9O2 — CID 146386538
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide
3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide (PubChem CID 146386538) has the molecular formula C21H17N9O2 and a molecular weight of 427.43 g/mol. Its IUPAC name is 3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide.
Molecular Properties
| Compound Name | 3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide |
|---|---|
| PubChem CID | 146386538 |
| Molecular Formula | C21H17N9O2 |
| Molecular Weight | 427.43 g/mol |
| Exact Mass | 427.15 |
| IUPAC Name | 3-amino-N-[(6-amino-2-pyridinyl)methyl]-6-imidazo[1,2-a]pyridin-6-yl-5-(1,3-oxazol-2-yl)pyrazine-2-carboxamide |
| SMILES | Nc1cccc(CNC(=O)c2nc(-c3ccc4nccn4c3)c(-c3ncco3)nc2N)n1 |
| InChI | InChI=1S/C21H17N9O2/c22-14-3-1-2-13(27-14)10-26-20(31)18-19(23)29-17(21-25-7-9-32-21)16(28-18)12-4-5-15-24-6-8-30(15)11-12/h1-9,11H,10H2,(H2,22,27)(H2,23,29)(H,26,31) |
| InChIKey | WJBZHWNSLMGASE-UHFFFAOYSA-N |
| XLogP | 1.94 |
| TPSA | 163.14 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.43 |
| LogP ≤ 5 | 1.94 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146386538 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.